PB 136 of 2025

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2025 (No. 11)

 

National Health Act 1953

I, REBECCA RICHARDSON, Assistant Secretary, PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 27 November 2025

REBECCA RICHARDSON
Assistant Secretary
PBS Listing, Pricing and Policy Branch
Technology Assessment and Access Division

Contents

1. Name

2. Commencement

3. Authority

4. Schedules

Schedule 1—Amendments

National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1. The whole of this instrument

1 December 2025

1 December 2025

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

[1] Schedule 1, after entry for Bimekizumab in the form Injection 160 mg in 1 mL single use pre‑filled pen [Maximum quantity or number of units: 2; Maximum number of repeats: 4]

insert:

 

 

20

2

5

 

 

 

20

4

3

 

 

Injection 320 mg in 2 mL single use pre-filled pen

20

1

5

 

 

 

20

2

3